Found: 17
Select item for more details and to access through your institution.
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 389, doi. 10.1111/j.1365-2036.2010.04534.x
- By:
- Publication type:
- Article
The effects of acute citalopram dosing on gastric motor function and nutrient tolerance in healthy volunteers.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 395, doi. 10.1111/j.1365-2036.2010.04522.x
- By:
- Publication type:
- Article
Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 358, doi. 10.1111/j.1365-2036.2010.04530.x
- By:
- Publication type:
- Article
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 414, doi. 10.1111/j.1365-2036.2010.04539.x
- By:
- Publication type:
- Article
Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 313, doi. 10.1111/j.1365-2036.2010.04537.x
- By:
- Publication type:
- Article
Review article: autoimmune pancreatitis - management of an emerging disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 291, doi. 10.1111/j.1365-2036.2010.04526.x
- By:
- Publication type:
- Article
The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 366, doi. 10.1111/j.1365-2036.2010.04519.x
- By:
- Publication type:
- Article
Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 304, doi. 10.1111/j.1365-2036.2010.04525.x
- By:
- Publication type:
- Article
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 413, doi. 10.1111/j.1365-2036.2010.04532.x
- By:
- Publication type:
- Article
Midodrine and furosemide-induced natriuresis in cirrhotics with ascites.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 415, doi. 10.1111/j.1365-2036.2010.04536.x
- By:
- Publication type:
- Article
Infliximab rescue therapy in steroid-refractory ulcerative colitis: is more really more?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 412, doi. 10.1111/j.1365-2036.2010.04529.x
- By:
- Publication type:
- Article
Alcohol consumption appears to protect against non-alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 378, doi. 10.1111/j.1365-2036.2010.04520.x
- By:
- Publication type:
- Article
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 340, doi. 10.1111/j.1365-2036.2010.04531.x
- By:
- Publication type:
- Article
Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 323, doi. 10.1111/j.1365-2036.2010.04517.x
- By:
- Publication type:
- Article
The interpretation of Rome III criteria and method of assessment affect the irritable bowel syndrome classification of children.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 403, doi. 10.1111/j.1365-2036.2010.04535.x
- By:
- Publication type:
- Article
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 349, doi. 10.1111/j.1365-2036.2010.04523.x
- By:
- Publication type:
- Article
The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 3, p. 333, doi. 10.1111/j.1365-2036.2010.04538.x
- By:
- Publication type:
- Article